Switch theme
Sign up to access all valuation multiples
IMD International Medical Devices SpA is a company manufacturing X-ray medical equipment with a complete range of mobile imaging systems.
1998
n/a
LTM Revenue $44.7M
LTM EBITDA $4.3M
$19.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
IMD International Medical has a last 12-month revenue (LTM) of $44.7M and a last 12-month EBITDA of $4.3M.
In the most recent fiscal year, IMD International Medical achieved revenue of $43.0M and an EBITDA of $4.9M.
IMD International Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See IMD International Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $44.7M | XXX | $43.0M | XXX | XXX | XXX |
| Gross Profit | $44.7M | XXX | $11.9M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 28% | XXX | XXX | XXX |
| EBITDA | $4.3M | XXX | $4.9M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $3.4M | XXX | $4.5M | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $2.5M | XXX | $2.5M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, IMD International Medical's stock price is EUR 1 (or $2).
IMD International Medical has current market cap of EUR 23.4M (or $26.3M), and EV of EUR 17.0M (or $19.1M).
See IMD International Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $19.1M | $26.3M | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, IMD International Medical has market cap of $26.3M and EV of $19.1M.
IMD International Medical's trades at 0.4x EV/Revenue multiple, and 3.9x EV/EBITDA.
Equity research analysts estimate IMD International Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IMD International Medical has a P/E ratio of 10.3x.
See valuation multiples for IMD International Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $26.3M | XXX | $26.3M | XXX | XXX | XXX |
| EV (current) | $19.1M | XXX | $19.1M | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 4.5x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBIT | 5.6x | XXX | 4.3x | XXX | XXX | XXX |
| EV/Gross Profit | 0.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 10.3x | XXX | 10.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -5.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialIMD International Medical's last 12 month revenue growth is 3%
IMD International Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
IMD International Medical's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IMD International Medical's rule of X is 17% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for IMD International Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | -18% | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IMD International Medical acquired XXX companies to date.
Last acquisition by IMD International Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . IMD International Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was IMD International Medical founded? | IMD International Medical was founded in 1998. |
| Where is IMD International Medical headquartered? | IMD International Medical is headquartered in Italy. |
| Is IMD International Medical publicy listed? | Yes, IMD International Medical is a public company listed on MIL. |
| What is the stock symbol of IMD International Medical? | IMD International Medical trades under IMD ticker. |
| When did IMD International Medical go public? | IMD International Medical went public in 2023. |
| Who are competitors of IMD International Medical? | Similar companies to IMD International Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of IMD International Medical? | IMD International Medical's current market cap is $26.3M |
| What is the current revenue of IMD International Medical? | IMD International Medical's last 12 months revenue is $44.7M. |
| What is the current revenue growth of IMD International Medical? | IMD International Medical revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of IMD International Medical? | Current revenue multiple of IMD International Medical is 0.4x. |
| Is IMD International Medical profitable? | Yes, IMD International Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of IMD International Medical? | IMD International Medical's last 12 months EBITDA is $4.3M. |
| What is IMD International Medical's EBITDA margin? | IMD International Medical's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of IMD International Medical? | Current EBITDA multiple of IMD International Medical is 4.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
